Pre-Clinical Activity of Tipifarnib in Cutaneous T-Cell Lymphoma

被引：0
|
作者：
Johnson, William [1 ]
Kohnken, Rebecca [2 ]
McNeil, Betina [3 ]
Wen, Jing [3 ]
McConnell, Kathleen [3 ]
Basem, William [3 ]
Burrows, Francis [4 ]
Porcu, Pierluigi [1 ]
Mishra, Anjali [3 ,5 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Kura Oncol, San Diego, CA USA
[5] Ohio State Univ, Dept Internal Med, Div Dermatol, Columbus, OH 43210 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Cutaneous T-cell lymphoma; Farnesyl transferase inhibitors; Tipifarnib;
D O I：
10.1016/j.clml.2018.07.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NHL-195
引用
收藏
页码：S283 / S284
页数：2
相关论文
共 50 条
  • [41] Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
    Lech-Maranda, Ewa
    Robak, Ewa
    Robak, Tadeusz
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (01) : 70 - 93
  • [42] The optimal use of bexarotene in cutaneous T-cell lymphoma
    Gniadecki, R.
    Assaf, C.
    Bagot, M.
    Dummer, R.
    Duvic, M.
    Knobler, R.
    Ranki, A.
    Schwandt, P.
    Whittaker, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (03) : 433 - 440
  • [43] Pediatric pityriasis lichenoides and cutaneous T-cell lymphoma
    Lam, Joseph
    Pope, Elena
    CURRENT OPINION IN PEDIATRICS, 2007, 19 (04) : 441 - 445
  • [44] Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
    Pelcovits, Ari
    Ollila, Thomas A.
    Olszewski, Adam J.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 989 - 998
  • [45] Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
    Zhang, Ping
    Zhang, Mingzhi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Cutaneous T-cell lymphoma: A paradigm for biological therapies
    Pichardo, DA
    Querfeld, C
    Guitart, J
    Kuzel, TM
    Rosen, ST
    LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1755 - 1765
  • [47] Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
    Prince, H. Miles
    Newland, Kate M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 625 - 634
  • [48] New and emerging therapies in cutaneous T-cell lymphoma
    Roccuzzo, Gabriele
    Macagno, Nicole
    Giordano, Silvia
    Fava, Paolo
    Quaglino, Pietro
    DERMATOLOGY REPORTS, 2025, 17 (01)
  • [49] CAUSES OF DEATH IN CUTANEOUS T-CELL LYMPHOMA PATIENTS
    Lebas, Eve
    Collins, Patrick
    Somja, Joan
    Nikkels, Arjen
    DERMATOLOGY, 2023, 239 (06) : 860 - 867
  • [50] The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma
    Spaccarelli, Natalie
    Rook, Alain H.
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 731 - +
12345